Brought to you by

Sandoz buys Durascan from AstraZeneca
09 Jul 2004
Executive Summary
Novartis AG's generics conglomerate Sandoz has acquired the Durascan division of AstraZeneca PLC for an undisclosed amount.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com